SULIMAN SHEHNAAZ (CIK 1713070) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-18). Recent activity: Sell TXG (5,359 shares), Sell TXG (364 shares), Buy TXG (8,829 shares), Buy RARE (7,751 shares), Sell RARE (5,740 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | 10x Genomics, Inc. (TXG) | Director | Sell | 5,359 | $174,644 |
| 2026-06-18 | 10x Genomics, Inc. (TXG) | Director | Sell | 364 | $12,112 |
| 2026-06-08 | 10x Genomics, Inc. (TXG) | Director | Buy | 8,829 | $0 |
| 2026-05-18 | Ultragenyx Pharmaceutical Inc. (RARE) | Director | Buy | 7,751 | $0 |
| 2026-05-18 | Ultragenyx Pharmaceutical Inc. (RARE) | Director | Sell | 5,740 | $144,189 |
| 2025-06-05 | 10x Genomics, Inc. (TXG) | Director | Buy | 15,357 | $0 |
| 2025-05-19 | Ultragenyx Pharmaceutical Inc. (RARE) | Director | Buy | 5,740 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18